Leadership Team

Paul Meister

Executive Chairman and Chief Executive Officer
inVentiv Health

Paul Meister, Executive Chairman and Chief Executive Officer of inVentiv Health, brings more than 25 years of operating and financial management experience to his role at the company. He also is co-founder of Liberty Lane Partners, LLC, part of a private investment group that acquired inVentiv Health in August 2010.

Mr. Meister previously served as Chairman of the Board of Thermo Fisher Scientific Inc. and Vice Chairman of Fisher Scientific International, Inc. During his tenure as an executive officer of Fisher Scientific, from 1991 to 2006, the company’s revenue and operating income grew at a compound annual growth rate of 15% and 23% respectively as operations grew from two countries to 27 and sales expanded into 140 countries worldwide. Fisher Scientific International provided services and products to pharmaceutical and biotech companies, medical research institutions and the scientific community.

Mr. Meister was a managing director of The Henley Group, Inc. from 1986 to 1992, and was a senior vice president of Abex, Inc. from 1992 to 1995.

Mr. Meister holds a Bachelor of Arts degree from the University of Michigan and an MBA from Northwestern University. He is a director of both M & F Worldwide Corp. and the LKQ Corporation, co-chair of the University of Michigan’s Life Sciences Institute External Advisory Board and serves on the Executive Advisory Board of the Chemistry of Life Processes Institute at Northwestern University.

Joe Massaro

Chief Financial Officer
inVentiv Health

Joe Massaro, Chief Financial Officer for inVentiv Health, has over 18 years of experience as a finance executive in complex service, distribution and manufacturing organizations.

Before joining inVentiv, Mr. Massaro was a Managing Director at Liberty Lane Partners, LLC, a private investment firm that applies its unique operational and financial expertise to its portfolio companies to achieve above-market returns. Prior to joining Liberty Lane Partners, Mr. Massaro served in several senior financial and operational roles at Thermo Fisher Scientific, including Senior Vice President Global Business Services and Vice President Corporate Finance and Accounting. In addition, Mr. Massaro served as Vice President Strategic Planning at Fisher BioPharma Services, a division of Thermo Fisher Scientific focused on providing outsourced clinical trial management and logistics to the pharmaceutical and biotechnology industries. Prior to Thermo Fisher, Mr. Massaro served in various capacities in the advisory business services practice at PricewaterhouseCoopers in Boston.

Mr. Massaro received a B.S. from Bentley University and a Master’s degree in Accounting and an MBA degree from Northeastern University.

William O'Donnell

President and COO
inVentiv Communications

As President and COO of inVentiv Communications, Mr. O'Donnell is responsible for strategic direction and oversight of inVentiv Communications and the 13 fully integrated companies within the division. He also oversees client relationships, new business activities and the division's operational backbone that includes the accounting/finance, human resources, marketing communications and technology departments.

Prior to joining inVentiv Communications (then known as inChord) in 2001, Mr. O'Donnell was Chief Financial Officer for Bank One's Retail Customer and Channel Group (now JPMorgan Chase). In this role, he led a team of finance and accounting professionals to provide decision support, financial reporting and analysis, financial control and strategic and capital planning for a business unit management team. During Mr. O'Donnell's 17 years with Bank One, he held a number of other positions, including CFO of the Business Banking Group, where he was responsible for the financial management of the small business unit. He was also corporate finance liaison, where he acted as the liaison between the Retail line of business CFO and CEO and the Banc One Corporation CFO and COO.

Mr. O'Donnell holds B.S. in Finance and Accounting from Miami University and an M.B.A. from the University of Dayton. He also completed the Executive Development Program at Darden School of Business, University of Virginia.

Paul Mignon

Chief Operating Officer
inVentiv Commercial
President
inVentiv Selling Solutions

Mr. Mignon successfully leads inVentiv Selling Solutions, the largest division of inVentiv encompassing all of the companies that relate to sales teams and sales support services including: Ventiv Sales and Marketing Teams, Total Data Solutions, MedConference, Blue Diesel, PROMOTECH, PRS Franklin companies, Ventiv Recruitment Services, inVentiv Resource Solutions, Ventiv Professional Development Group as well as the supporting Business Development team.

In his current role, Mr. Mignon is responsible for the development and execution of comprehensive, customized selling solutions that support many of the major pharmaceutical firms, as well as effectively delivering cross-selling and integrated solutions to clients that include services across the broader inVentiv organization.

Mr. Mignon joined inVentiv in 2002 when he assumed the leadership role for the sales organization. Since that time, he has expanded the active client roster and significantly diversified their service portfolio. As a consultative business partner, Mr. Mignon has strengthened and stabilized client relationships by providing innovative products and services to meet the challenges of the dynamic pharmaceutical market place.

Mr. Mignon's depth of experience is built on a successful 14-year career with Johnson & Johnson. During his tenure, he was recognized for many significant accomplishments while holding various leadership roles within the J & J Family of Companies, including National Sales Director, Sales Training Director, Product Director and Division Manager.

Mr. Mignon is a graduate of Lafayette College where he received his B.A. in History. He is a member of the editorial board for Product Management Today and serves on the Board of Directors for the Cancer Institute of New Jersey.